RBC Bioscience (ROCO:6848) ROE % Adjusted to Book Value : 11.68% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is RBC Bioscience ROE % Adjusted to Book Value?

RBC Bioscience's ROE % for the quarter that ended in Jun. 2024 was 10.75%. RBC Bioscience's PB Ratio for the quarter that ended in Jun. 2024 was 0.92. RBC Bioscience's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 11.68%.

RBC Bioscience ROE % Adjusted to Book Value Historical Data

The historical data trend for RBC Bioscience's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RBC Bioscience ROE % Adjusted to Book Value Chart

RBC Bioscience Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

7.52

1.80

3.02

RBC Bioscience Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial						4.36	-4.54	1.86	3.98	11.68

Competitive Comparison of RBC Bioscience's ROE % Adjusted to Book Value

For the Biotechnology subindustry, RBC Bioscience's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RBC Bioscience's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RBC Bioscience's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where RBC Bioscience's ROE % Adjusted to Book Value falls into.

RBC Bioscience ROE % Adjusted to Book Value Calculation

RBC Bioscience's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	2.63%	/	0.87
	=	3.02%

RBC Bioscience's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	10.75%	/	0.92
	=	11.68%

RBC Bioscience ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

RBC Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 235, Baoqiao Road, 3rd Floor, No. 132, New Taipei City, TWN, 23145

Website

https://www.rbcbioscience.com

RBC Bioscience Corp is a bio sciences company. Its products include Real Genomics, MagCore Automated Nucleic Acid Extractor, and MagCore Nucleic Acid Extraction KIT.

RBC Bioscience Headlines

No Headlines